Overview

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Status:
Withdrawn
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Phase 2 Study Evaluating Gerilimzumab's Safety/Efficacy for Patients with an Inadequate Response to MTX or a TNFα Antagonist in Rheumatoid Arthritis.
Phase:
Phase 2
Details
Lead Sponsor:
Bird Rock Bio, Inc.
Collaborators:
Pharmagenix
Techtrials Pesquisa e Tecnologia Ltda
Treatments:
Folic Acid
Methotrexate
Vitamin B Complex